If antipsychotic polypharmacy, which is not recommended, is associated with a greater risk of metabolic syndrome, the spread of polypharmacy is a serious concern. However, it remains unclear among ...

They were also taking antipsychotic medicines and had a ... After four months on a keto diet, none of the participants had ...

Sepranolone, a Phase 2b-ready neurosteroid in development for Tourette syndrome (US prevalence of ... clinical development landscape in metabolic disease have prompted our review.” ...

About Relmada Therapeutics, Inc. Relmada Therapeutics is a clinical-stage biotechnology company committed to advancing innovative breakthrough therapies that have the potential to bring meaningful ...

Stress is another important driving factor for many psychiatric disorders like anxiety disorders and depression, along with physical ailments such as irritable bowel syndrome. This is why it has ...

Objectives To increase the frequency and quality of screening for the metabolic syndrome in people prescribed continuing antipsychotic medication. Design An audit-based, quality improvement programme ...

Researchers find new drug associations with floppy iris syndrome, including alpha-1 blockers, atypical antipsychotics, ...

The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...

metabolic syndrome, type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease. Advancements in ...

Past studies have shown that the human sweet taste receptor conveys sweet perception in the mouth and may help regulate glucose metabolism throughout the body.